EDITORIAL
Published on 13 Sep 2024
Editorial: Novel preclinical model, biomarker, treatment and drug delivery to address immune evasion in cancer
doi 10.3389/fimmu.2024.1486819
- 358 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Novel Preclinical Model, Biomarker, Treatment and Drug Delivery to Address Immune Evasion in Cancer
Novel Preclinical Model, Biomarker, Treatment and Drug Delivery to Address Immune Evasion in Cancer
12k
Total downloads
35k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 09 Sep 2024
The NSCLC immunotherapy response predicted by tumor-infiltrating T cells via a non-invasive radiomic approach
doi 10.3389/fimmu.2024.1379812
- 903 views
ORIGINAL RESEARCH
Published on 08 May 2024
Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1
doi 10.3389/fimmu.2024.1365894
- 2,435 views
- 4 citations
ORIGINAL RESEARCH
Published on 03 Jan 2024
Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer
doi 10.3389/fimmu.2023.1307588
- 2,778 views
- 4 citations
ORIGINAL RESEARCH
Published on 28 Sep 2023
A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer
![A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer](https://www.frontiersin.org/files/myhome article library/1272570/1272570_Thumb_400.jpg)
doi 10.3389/fimmu.2023.1272570
- 2,210 views
- 2 citations
ORIGINAL RESEARCH
Published on 21 Aug 2023
Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
doi 10.3389/fimmu.2023.1176647
- 3,328 views
- 11 citations
ORIGINAL RESEARCH
Published on 11 Aug 2023
Typing and modeling of hepatocellular carcinoma based on disulfidptosis-related amino acid metabolism genes for predicting prognosis and guiding individualized treatment
doi 10.3389/fonc.2023.1204335
- 2,362 views
- 5 citations
SYSTEMATIC REVIEW
Published on 14 Jul 2023
Development and validation of prognostic risk prediction models for hepatocellular carcinoma patients treated with immune checkpoint inhibitors based on a systematic review and meta-analysis of 47 cohorts
doi 10.3389/fimmu.2023.1215745
- 1,901 views
- 4 citations
ORIGINAL RESEARCH
Published on 30 Jun 2023
Immunogenic landscape and risk score prediction based on unfolded protein response (UPR)-related molecular subtypes in hepatocellular carcinoma
doi 10.3389/fimmu.2023.1202324
- 2,836 views
- 1 citation
BRIEF RESEARCH REPORT
Published on 21 Jun 2023
MK2 drives progression of pancreas and colon cancers by suppressing CD8+ T cell cytotoxic function and is a potential immunotherapy target
doi 10.3389/fimmu.2023.1212100
- 1,783 views
- 2 citations
ORIGINAL RESEARCH
Published on 05 May 2023
Establishment of a novel lysosomal signature for the diagnosis of gastric cancer with in-vitro and in-situ validation
doi 10.3389/fimmu.2023.1182277
- 2,240 views
- 12 citations
ORIGINAL RESEARCH
Published on 03 May 2023
Elevated MPP6 expression correlates with an unfavorable prognosis, angiogenesis and immune evasion in hepatocellular carcinoma
doi 10.3389/fimmu.2023.1173848
- 3,462 views
- 3 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 35kTopic views
- 21kArticle views
- 12kArticle downloads